
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5272195
[patent_doc_number] => 20090075971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DERIVATIVES OF 2-ALKOXY-3,4,5-TRIHYDROXY-ALKYL AMIDES, PREPARATION AND USE THEREOF, AND COMPOSITIONS CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/267692
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18754
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12267692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/267692 | Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same | Nov 9, 2008 | Issued |
Array
(
[id] => 5265559
[patent_doc_number] => 20090118244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'BENZODIAZEPINONE COMPOUNDS USEFUL IN THE TREATMENT OF SKIN CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/266239
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21000
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118244.pdf
[firstpage_image] =>[orig_patent_app_number] => 12266239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/266239 | Benzodiazepinone compounds useful in the treatment of skin conditions | Nov 5, 2008 | Issued |
Array
(
[id] => 6071260
[patent_doc_number] => 20110046111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'QUINAZOLINE LINKED PYRROLO[2,1-C][1, 4]BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/920654
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7393
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046111.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920654 | Quinazoline linked pyrrolo[2,1-C][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof | Oct 30, 2008 | Issued |
Array
(
[id] => 6064268
[patent_doc_number] => 20110201600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'CHALCONE LINKED PYRROLO[2,1-C][1, 4]BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/921016
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10767
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201600.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921016 | Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof | Oct 30, 2008 | Issued |
Array
(
[id] => 8675505
[patent_doc_number] => 08383618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/921841
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9226
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12921841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921841 | C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof | Oct 30, 2008 | Issued |
Array
(
[id] => 6002998
[patent_doc_number] => 20110118237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/934594
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9214
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118237.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934594 | Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof | Oct 30, 2008 | Issued |
Array
(
[id] => 5324266
[patent_doc_number] => 20090062256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/257809
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49780
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062256.pdf
[firstpage_image] =>[orig_patent_app_number] => 12257809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/257809 | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION | Oct 23, 2008 | Abandoned |
Array
(
[id] => 6007923
[patent_doc_number] => 20110059954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'CGRP ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/682760
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53207
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059954.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682760 | CGRP ANTAGONISTS | Oct 15, 2008 | Abandoned |
Array
(
[id] => 131835
[patent_doc_number] => 07700598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/246067
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71230
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246067 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | Oct 5, 2008 | Issued |
Array
(
[id] => 14057
[patent_doc_number] => 07807826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Purification of a crude lactam mixture by means of melt crystallization'
[patent_app_type] => utility
[patent_app_number] => 12/244452
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2247
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807826.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244452
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244452 | Purification of a crude lactam mixture by means of melt crystallization | Oct 1, 2008 | Issued |
Array
(
[id] => 6071242
[patent_doc_number] => 20110046093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/680353
[patent_app_country] => US
[patent_app_date] => 2008-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 63525
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680353
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680353 | Pyrimidine derivatives as protein kinase inhibitors | Sep 28, 2008 | Issued |
Array
(
[id] => 6551603
[patent_doc_number] => 20100222575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'POLO-LIKE KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/680142
[patent_app_country] => US
[patent_app_date] => 2008-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8907
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222575.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680142 | Polo-like kinase inhibitors | Sep 24, 2008 | Issued |
Array
(
[id] => 7808040
[patent_doc_number] => 20120058994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/680060
[patent_app_country] => US
[patent_app_date] => 2008-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8229
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058994.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680060
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680060 | Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate | Sep 24, 2008 | Issued |
Array
(
[id] => 7523078
[patent_doc_number] => 08026234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Polo-like kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/237306
[patent_app_country] => US
[patent_app_date] => 2008-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 132074
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026234.pdf
[firstpage_image] =>[orig_patent_app_number] => 12237306
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/237306 | Polo-like kinase inhibitors | Sep 23, 2008 | Issued |
Array
(
[id] => 5429106
[patent_doc_number] => 20090088416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'DEUTERIUM-ENRICHED LAPAQUISTAT'
[patent_app_type] => utility
[patent_app_number] => 12/233690
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5031
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088416.pdf
[firstpage_image] =>[orig_patent_app_number] => 12233690
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/233690 | DEUTERIUM-ENRICHED LAPAQUISTAT | Sep 18, 2008 | Abandoned |
Array
(
[id] => 5272284
[patent_doc_number] => 20090076060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED TEMSIROLIMUS'
[patent_app_type] => utility
[patent_app_number] => 12/209043
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2880
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076060.pdf
[firstpage_image] =>[orig_patent_app_number] => 12209043
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/209043 | DEUTERIUM-ENRICHED TEMSIROLIMUS | Sep 10, 2008 | Abandoned |
Array
(
[id] => 5272201
[patent_doc_number] => 20090075977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED MK0974'
[patent_app_type] => utility
[patent_app_number] => 12/208981
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3407
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208981
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208981 | DEUTERIUM-ENRICHED MK0974 | Sep 10, 2008 | Abandoned |
Array
(
[id] => 5331316
[patent_doc_number] => 20090111793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF A BETA PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/207355
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46868
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111793.pdf
[firstpage_image] =>[orig_patent_app_number] => 12207355
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/207355 | HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF A BETA PROTEIN PRODUCTION | Sep 8, 2008 | Abandoned |
Array
(
[id] => 5586011
[patent_doc_number] => 20090105213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Lactam compounds useful as protein kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/231661
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70076
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231661 | Lactam compounds useful as protein kinase inhibitors | Sep 3, 2008 | Issued |
Array
(
[id] => 5453329
[patent_doc_number] => 20090069366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'DEUTERIUM-ENRICHED TACROLIMUS'
[patent_app_type] => utility
[patent_app_number] => 12/202275
[patent_app_country] => US
[patent_app_date] => 2008-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3553
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069366.pdf
[firstpage_image] =>[orig_patent_app_number] => 12202275
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/202275 | DEUTERIUM-ENRICHED TACROLIMUS | Aug 30, 2008 | Abandoned |